Your session is about to expire
← Back to Search
day 3 uterine transfer for Infertility (PRECiSE Trial)
N/A
Waitlist Available
Led By Werner Neuhausser, MD PhD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Summary
This trial is testing whether it's better to transfer embryos on day 3 or day 5 of IVF in patients with 5 or fewer embryos. The goal is to find the best way to maximize the chances of success for these patients.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
live birth
Secondary outcome measures
Clinical pregnancy
Multiple pregnancy
Ongoing pregnancy
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: day 5 embryo transferExperimental Treatment1 Intervention
embryo transfer 5 days after fertilization
Group II: day 3 embryo transferExperimental Treatment1 Intervention
embryo transfer 3 days after fertilization
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
day 3 uterine transfer
2021
N/A
~10
day 5 uterine transfer
2021
N/A
~10
Find a Location
Who is running the clinical trial?
Beth Israel Deaconess Medical CenterLead Sponsor
840 Previous Clinical Trials
13,011,709 Total Patients Enrolled
Boston IVFOTHER
19 Previous Clinical Trials
20,214 Total Patients Enrolled
18 Trials studying Infertility
19,914 Patients Enrolled for Infertility
Werner Neuhausser, MD PhDPrincipal Investigator - Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger